Marte Martinez, MD
Pain Medicine · Laredo, TXNPI 1467658047
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (46.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Boston Scientific at 30.1% of the total. Reporting peaked in 2021 at $3,181 and has fallen 57.0% since, to $1,369 in 2025.
Across 126 payments — averaging $73.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Spinal Simplicity, LLC$2K
- Relievant Medsystems, Inc.$922
- Abbott$828
- Medtronic$708
- Vertos Medical, Inc.$536
- plus $2K from 16 others
Across 27 payments — averaging $4579.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endo Pharmaceuticals Inc.$96K
- Boston Scientific$28K
What the payments were for
- Travel & lodging$4,31046%
- Food & beverage$3,73140%
- Education$1,27914%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 33 | $2,809 |
| Spinal Simplicity, LLC | 2 | $1,957 |
| Relievant Medsystems, Inc. | 11 | $922 |
| Abbott | 22 | $828 |
| Medtronic(2 entities) | 10 | $708 |
| Vertos Medical, Inc. | 3 | $536 |
| Si-bone, Inc. | 8 | $483 |
| MML US, Inc. | 7 | $352 |
| Radius Health, Inc. | 13 | $226 |
| Stimwave Technologies Incorporated | 1 | $109 |
| Mallinckrodt Hospital Products Inc. | 1 | $75 |
| AbbVie | 1 | $70 |
| Stryker | 1 | $59 |
| Collegium Pharmaceutical, Inc. | 3 | $42 |
| Vertiflex, Inc. | 3 | $38 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Lundbeck LLC | 1 | $17 |
| Saluda Medical Americas, Inc. | 1 | $16 |
| EMD Serono, Inc. | 1 | $12 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
| Daiichi Sankyo Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$1,957
- SPECTRA WAVEWRITER$1,747
- Intracept$1,550
- mild Device Kit$536
- OSTEOCOOL RF ABLATION$495
- IFUSE IMPLANT SYSTEM$352
- ETERNA$280
- GENERAL PAIN MANAGEMENT$273
- SUPERION$111
- PROCLAIM$110
- ReActiv8$109
How this compares
$9,320 in reported general payments places this provider in the 75th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TymlosAbaloparatide | 30 | $77,820 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,466 | $40,474 |
| NucyntaTapentadol Hcl | 20 | $17,421 |
| Fentanyl | 120 | $11,100 |
| Gabapentin | 775 | $9,562 |
| Pregabalin | 480 | $9,552 |
| Diclofenac Sodium | 448 | $6,947 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 201 | $5,950 |
| Hysingla ErHydrocodone Bitartrate | 13 | $5,529 |
| Hydrocodone Bitartrate ErHydrocodone Bitartrate | 19 | $5,120 |
| Morphine Sulfate ErMorphine Sulfate | 189 | $5,043 |
| Tramadol Hcl | 355 | $3,307 |
| Tramadol Hcl ErTramadol Hcl | 56 | $3,144 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 175 | $2,898 |
| Tizanidine Hcl | 255 | $2,376 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Radius Health, Inc.Tymlos | $226 | $77,82030 claims |
| Collegium Pharmaceutical, Inc.Nucynta | $42 | $17,42120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 583 pain medicine providers in Texas.
Other pain medicine in Laredo
- Melissa MurphyGrapevine$653K
- Shiraz YazdaniLubbock$514K
- Aaron CalodneyTyler$296K
- Candice BurnetteSugar Land$265K
- Ashley Bailey-ClassenFort Worth$244K
- Grant ChenHouston$175K
- Gunjan PatelHouston$166K
- Anthony BergRockwall$165K
- Puneet SayalCorpus Christi$153K
- Eduardo GarciaWebster$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.